Lead Product(s): MRT5500
Therapeutic Area: Infections and Infectious Diseases Product Name: MRT5500
Highest Development Status: IND Enabling Product Type: Vaccine
Partner/Sponsor/Collaborator: Translate Bio
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 15, 2020
Preclinical evaluation of MRT5500, importantly, demonstrated a favorable immune response profile against SARS-CoV-2. These data support the selection of MRT5500 for clinical development.